Uni-Bio Science Group Limited
HKSE: 0690.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Zhi Gang Zhao
- Employees
- 487
- Headquarters
- Sha Tin, Hong Kong SAR China
- IPO year
- 2001
- Market cap
- HK$549.4M
- Website
- https://www.uni-bioscience.com
Loading 0690…
Loading profile data…Frequently asked questions about 0690
What does Uni-Bio Science Group Limited (0690.HK) do?
Uni-Bio Science Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of biological and chemical pharmaceutical products to treat human diseases in the People's Republic of China. The company provides GeneTime, a prescription biological drug for wound healing; GeneSoft, an EGF eye drop for d...
Where does 0690.HK trade?
Uni-Bio Science Group Limited (0690.HK) trades on the Hong Kong Stock Exchange.
What sector is 0690.HK in?
Uni-Bio Science Group Limited (0690.HK) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Uni-Bio Science Group Limited?
Zhi Gang Zhao is the chief executive officer of Uni-Bio Science Group Limited (0690.HK).
Where is Uni-Bio Science Group Limited headquartered?
Uni-Bio Science Group Limited is headquartered in Hong Kong SAR China.
Does 0690.HK pay a dividend?
Yes — Uni-Bio Science Group Limited (0690.HK) paid a trailing twelve-month dividend of HKD 0.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 0690.HK go public?
Uni-Bio Science Group Limited (0690.HK) completed its initial public offering in 2001.